MPH Health Care

Earnings Release • Aug 31, 2011

News Details

Corporate | 31 August 2011 13:18

MPH Mittelständische Pharma Holding AG:

MPH Mittelständische Pharma Holding AG / Key word(s): Half Year Results/Development of Sales

31.08.2011 / 13:18

---

MPH Mittelständische Pharma Holding AG:

Half-year report 2011 now available

Compared to the same period of the previous year the turnover increased in the first half of the year 2011 by +28% and reached 70.27 Mill.

The achieved EBIT margin was 8.7%. A net profit/share of 13 Cent was earned.

The company MPH Mittelständische Pharma Holding AG today presents the semi-annual report for the first six months of 2011.

During the first six months of 2011 the MPH corporation achieved a turnover to the amount of 70.27 Mill. Euro and a period surplus to the amount of 5.03 Mill. Euro. The earnings before interest and taxes (EBIT) was 6.11 Mill. Euro. The earnings before interest, taxes, depreciation and amortisation (EBITDA) was 6.53 Mill. Euro.

An increasing number of pharmacists, doctors and patients are placing their trust in medications that are being made available by the MPH group in the therapeutic areas oncology, HIV, rheumatology, neurology and cardiovascular diseases.

The corporate group is therefore also for the current business year 2011 anticipating a continued growth in turnover and earnings.

About the company MPH Mittelständische Pharma Holding AG:

The Berlin based company MPH Mittelständische Pharma Holding AG has strategically concentrated its activities on growth segments in the pharmaceutical market. With pharmaceutical products based on patent-free and patent-protected active substances, which are made available through the MPH group in the therapeutic areas oncology, HIV, rheumatology, neurology and cardiovascular diseases, a contribution is made towards cost reduction in the healthcare sector.

MPH Mittelständische Pharma Holding AG has been listed on the stock exchange (Open Market) in Frankfurt.

Key capital market data for MPH Mittelständische Pharma Holding AG:

Subscribed Capital: EUR 38.050.000

Stock exchange listed class of shares: Owner held-preferred shares

Number of circulating preference shares: 19.025.000

ISIN: DE000A0NF697

WKN: A0NF69

Stock Exchange code: 93MV

Contact:

MPH Mittelständische Pharma Holding AG

Patricia Blechinger

Hubertusallee 73

14193 Berlin

Phone: +49 (0)30 897 308 660

Mail: ir@mph-ag.de

End of Corporate News

---

31.08.2011 Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG.

The issuer is solely responsible for the content of this announcement.

DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de

---

137700  31.08.2011